Citadel Advisors’s PolyPid PYPD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-410
Closed -$8.58K 15345
2022
Q4
$8.58K Sell
410
-100
-20% -$2.58K ﹤0.01% 13741
2022
Q3
$18K Sell
510
-197
-28% -$24.4K ﹤0.01% 12112
2022
Q2
$98K Sell
707
-43
-6% -$6.43K ﹤0.01% 11430
2022
Q1
$123K Sell
750
-53
-7% -$8.03K ﹤0.01% 12066
2021
Q4
$138K Buy
+803
New +$170K ﹤0.01% 12375

Other funds holding PYPD

Citadel Advisors's PYPD Position: Q1 2026 in Review

Citadel Advisors increased its PolyPid (PYPD) stake by 439% in Q1 2026, buying an estimated $208K and bringing the position to 57,769 shares worth $253K. The position accounts for ﹤0.01% of the portfolio, ranked #10881.

Citadel Advisors first reported a position in PYPD in Q2 2020 and has held it in 11 quarters since. The position peaked at $1.65M in Q2 2020. 19 funds tracked by Wall St. Rank hold PYPD as of Q1 2026.

  • Citadel Advisors held 57,769 shares of PolyPid worth $253K as of Q1 2026.
  • Citadel Advisors bought 47,046 PolyPid shares in Q1 2026, an estimated $208K.
  • PolyPid made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #10881 holding.
  • Citadel Advisors first reported a position in PolyPid in Q2 2020 and has held it in 11 quarters since.
  • Citadel Advisors's PolyPid position peaked at $1.65M in Q2 2020.
  • 19 funds tracked by Wall St. Rank held PolyPid as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.